Laboratory Corporation of America, which is based in Burlington, intends to take over Monogram Biosciences Inc. following a merger agreement announced Tuesday.
In the deal, LabCorp will acquire all of the outstanding shares of Monogram in a cash tender offer of $4.55 a share. The implied total enterprise value is about $155 million, according to a Lab-Corp press release.
Monogram, based in San Francisco, specializes in treatments and testing for infectious diseases, cancer and other serious diseases. It is a leader in HIV testing and oncology products.
■ Have an idea for a business story? Call 727-7234 or send it to businessnews@journalnow.com.
Email
Facebook
Google
Twitter
Favorites
More
Advertisement